Our findings reveal the essential regulatory role of METTL3/GBAP1/miR-22-3p/BMPR1A/SMAD signaling axis and highlight the great importance of m6A modification in modulating GBAP1 expression post-transcriptionally in HCC. Here, METTL3 is linked to hepatocellular carcinoma.